市場調查報告書
商品編碼
1603841
功能性內視鏡鼻竇手術的市場至2030年的預測:按產品類型、手術、患者類型、應用、最終用戶和地區的全球分析Functional Endoscopic Sinus Surgery Market Forecasts to 2030 - Global Analysis By Product Type, Procedure, Patient Type, Application, End User and By Geography |
根據 Stratistics MRC 的資料,2024年全球功能性內視鏡鼻竇手術市場規模為 34.1億美元,預測期內年複合成長率為 11.6%,預計到2030年將達到 65.9億美元。
一種稱為功能性內視鏡鼻竇手術(FESS)的微創手術使用內視鏡改善鼻竇通氣和功能,以治療慢性鼻竇炎和其他鼻竇相關疾病。為了恢復正常氣流,必須清除息肉或感染組織等阻塞物。在手術過程中,醫生使用內視鏡(帶有攝影機的細管)進入鼻竇並清除黏液或異常生長物等阻塞物。 FESS 改善鼻竇通氣和引流,減少發炎並緩解症狀。當其他治療方法(例如藥物)無法解決鼻竇問題時,通常會建議這樣做。
根據美國疾病管制與預防中心( 美國)的資料,美國有超過 2,800萬名成年人被診斷出患有鼻竇炎。大約 11.6%的美國成年人患有這種疾病。根據美國生物技術資訊中心的資料,2015年,美國約有6%至13%的兒童在3歲時患有慢性鼻竇炎或急性鼻竇炎。
人們對鼻竇疾病的認知不斷提高
隨著越來越多的人意識到鼻竇疾病以及越來越多的人接受診斷和治療,功能性內視鏡鼻竇手術(FESS)市場受到了重大影響。計劃和醫療保健組織進行宣傳活動,教育人們了解慢性鼻竇炎的症狀和後果,並敦促他們諮詢醫生。這種認知的提高將改善患者治療鼻竇相關疾病的結果,促進 FESS 作為一種有效的治療方法,並鼓勵早期療育。
農村地區意識淡薄
在農村地區,缺乏對功能性內視鏡鼻竇手術(FESS)的了解會對患者的治療結果和服務可近性產生負面影響。由於許多人仍然不知道該手術的好處和可近性,因此與鼻竇相關的疾病仍未被診斷和治療。這種無知增加了慢性鼻竇炎的盛行率及其相關後果。這增加了這些人群的整體健康負擔,並加劇了現有的醫療保健不平等。
改善醫療保健服務的獲取
透過改善醫療服務的可近性,可以實現鼻竇相關疾病的早期治療,推動功能性內視鏡鼻竇手術(FESS)市場的發展。醫療基礎設施的改善意味著更多的患者可以獲得專科護理,特別是在服務不足和農村地區。門診手術中心(ASC)和耳鼻喉科專科中心的發展使得門診手術速度更快,減少了等待時間並改善了患者的治療效果。除了增加對 FESS 的了解之外,這種改善的獲取方式還將促進早期療育,並最終提高患者滿意度和醫療保健。
外科醫生短缺且缺乏專業知識
由於缺乏熟練的外科醫生,功能性內視鏡鼻竇手術(FESS)領域的患者照護受到嚴重阻礙。在許多地區,特別是農村地區,缺乏訓練有素的耳鼻喉科醫生,導致手術等待時間較長,慢性鼻竇炎的治療方案不足。熟練外科醫生的短缺導致手術成功率參差不齊,不僅會延誤重要的手術治療,還會影響患者的整體治療結果。因此,這種知識的缺乏限制了 FESS 市場的擴張潛力,並加劇了醫療保健不平等。
COVID-19 的影響
功能性內視鏡鼻竇手術(FESS)市場受到 COVID-19 大流行的嚴重影響,導致常規臨床實踐和擇期手術發生重大中斷。由於許多醫療機構優先考慮 COVID-19 患者,因此 FESS 等非緊急手術被推遲。患者無法及時治療,導致病情惡化,包括慢性鼻竇炎。此外,向遠端醫療的轉變減少了親自就診的次數,對於患者來說,了解手術選擇和接受手術變得困難。
預計手術器械產業在預測期內將是最大的。
手術器械區隔估計是最大的。技術的發展和對微創手術不斷成長的需求推動 FESS 市場的手術器械領域。工具設計精確度和人體工學的改進可帶來更好的手術效果和更快的患者復原時間。慢性鼻竇炎發生率的增加和門診手術需求的增加進一步增加了對專業手術設備的需求。此外,內視鏡鼻竇手術在新興國家的普及為設備製造商創造新的商機。
預計專科診所產業在預測期內年複合成長率最高
預計專科診所領域在預測期內的年複合成長率最高。這些診所提供有關鼻竇問題的專業治療和知識,吸引了尋求尖端治療方法的人。經常使用尖端技術和熟練的外科醫生為患者提供最好的結果。專科診所也透過致力於複雜病例、翻修手術和專門手術來滿足有特殊需求的患者。專科診所透過提供個人化治療和尖端治療技術,為 FESS 產業的擴張做出貢獻。
由於生活方式的改變和都市區污染的增加導致鼻竇相關疾病的增加,預計亞太地區在預測期內將佔據最大的市場佔有率。由於尖端醫療技術的進步和醫療保健基礎設施的擴大,FESS 手術現在得到了更廣泛的應用。需求也受到不斷成長的中產階級對鼻竇治療方案更了解的影響。中國、日本和印度等國家的政府醫療計劃和合格的耳鼻喉科醫師進一步促進了 FESS 在該地區的使用。
由於引起慢性鼻竇炎及相關疾病的過敏和環境因素的高發生率,預計北美在預測期內將呈現最高的年複合成長率。醫療保健側重於複雜的醫療系統和微創手術方法。最近的技術進步,例如更好的導航和成像系統,改善手術結果並吸引更多患者。此外,由於良好的保險覆蓋範圍、償付規定以及對鼻竇健康的普遍認知,FESS 手術在整個全部區域變得越來越廣泛和受到青睞。
According to Stratistics MRC, the Global Functional Endoscopic Sinus Surgery Market is accounted for $3.41 billion in 2024 and is expected to reach $6.59 billion by 2030 growing at a CAGR of 11.6% during the forecast period. A minimally invasive procedure called functional endoscopic sinus surgery (FESS) uses endoscopic procedures to improve sinus outflow and function in order to treat chronic sinusitis and other sinus-related diseases. To return the airflow to normal, obstructions like polyps or infected tissue must be removed. The surgery involves using an endoscope, a thin tube with a camera, to access and remove blockages, such as mucus or abnormal growths, from the sinuses. FESS improves airflow and drainage in the sinuses, reducing inflammation and relieving symptoms. It is typically recommended when other treatments, such as medication, have not been effective in managing sinus issues.
According to the Centers for Disease Control and Prevention (CDC), over 28 million adults in the U.S. have been diagnosed with sinusitis. This condition affects about 11.6% of all adults in the country. According to the National Center for Biotechnology Information, in 2015, in the U.S., about 6 to 13% of children developed chronic rhinosinusitis and acute rhinosinusitis by the age of 3 years.
Growing awareness of sinus disorders
As more people become aware of sinus conditions, the market for functional endoscopic sinus surgery (FESS) is greatly impacted since more people are being diagnosed and treated. Campaigns to educate people about the signs and consequences of chronic sinusitis are run by advocacy organizations and healthcare organizations, encouraging people to consult a doctor. This increased awareness improves patient outcomes in managing sinus-associated illnesses and promotes FESS as an effective treatment option and encourages earlier intervention, which in turn drives demand for surgical treatments and related healthcare services.
Limited awareness in rural areas
In rural locations, a lack of knowledge about functional endoscopic sinus surgery (FESS) has a detrimental effect on patient outcomes and service accessibility. Many people are still unaware of the advantages and accessibility of this technique, which causes sinus-related disorders to go undiagnosed and untreated. Patients may turn to useless home remedies or forego seeking medical attention entirely as a result of this ignorance, which raises the prevalence of chronic sinusitis and its related consequences. As a result, these groups' general health burden rises, escalating already-existing healthcare inequities.
Improved access to healthcare services
Timely treatment of sinus-related illnesses is made possible by improved access to healthcare services, which in turn boosts the market for functional endoscopic sinus surgery (FESS). More patients can access specialist care as healthcare infrastructure grows, especially in underserved and rural areas. Faster, outpatient operations are made possible by the growth of ambulatory surgery centers (ASCs) and ENT specialist centers, which lower wait times and enhance patient outcomes. In addition to increasing knowledge of FESS, this improved accessibility promotes early intervention, which eventually improves patient satisfaction and health management.
Shortage of surgeon availability and expertise
Patient care in the functional endoscopic sinus surgery (FESS) sector is severely hampered by the lack of available and skilled surgeons. There is a shortage of trained ENT doctors in many places, especially rural ones, which results in lengthy procedure wait times and insufficient alternatives for treating chronic sinusitis. Due to a lack of skilled surgeons, surgical success rates may vary, which affects overall patient outcomes in addition to delaying critical surgical treatments. As a result, this lack of knowledge limits the FESS market's potential for expansion and makes healthcare inequities worsen.
Covid-19 Impact
The functional endoscopic sinus surgery (FESS) market was significantly impacted by the COVID-19 pandemic, which caused major interruptions in routine care and elective surgeries. Numerous medical facilities put COVID-19 patients first, which caused non-urgent operations, like FESS, to be postponed. Patients were unable to receive prompt treatment, which made diseases like chronic sinusitis worse. Furthermore, the move to telemedicine reduced in-person consultations, which made it more difficult for patients to learn about and obtain surgical choices.
The surgical instruments segment is expected to be the largest during the forecast period
The surgical instruments segment is estimated to be the largest. Technological developments and rising demand for minimally invasive procedures are driving the surgical instruments section of the FESS market. Improved precision and ergonomics in tool design lead to better surgical results and shorter recovery times for patients. The need for specialized surgical equipment is being further fuelled by the increasing frequency of chronic sinusitis and the growing desire for outpatient operations. Additionally, new opportunities are being created for instrument producers by the growing use of endoscopic sinus surgery in emerging economies.
The specialty clinics segment is expected to have the highest CAGR during the forecast period
The specialty clinics segment is anticipated to witness the highest CAGR during the forecast period. These clinics draw individuals looking for cutting-edge treatment choices because they provide specialized care and knowledge in sinus issues. To achieve the best possible results for their patients, they frequently use cutting-edge technologies and skilled surgeons. Specialty clinics also serve patients with particular requirements by concentrating on complicated cases, revision surgeries, and specialist procedures. Specialty clinics help the FESS industry expand by providing individualized care and cutting-edge treatment techniques.
Asia Pacific is expected to have the largest market share during the forecast period due to an increase in sinus-related disorders as a result of changing lifestyles and growing urban pollution. FESS operations are now more widely available because to advances in cutting-edge medical technology and expanding healthcare infrastructure. Demand is also influenced by a growing middle class that is more knowledgeable about sinus treatment choices. The use of FESS in the region is further fuelled by government healthcare programs and the availability of qualified ENT doctors in nations like China, Japan, and India.
North America is projected to witness the highest CAGR over the forecast period, owing to a high incidence of allergies and environmental factors contributing to chronic sinusitis and related conditions. Adoption is aided by a sophisticated healthcare system and a focus on minimally invasive surgical methods. Recent advances in technology, such as better navigation and imaging systems, improve surgical results and draw in more patients. Furthermore, FESS operations are more widely available and well-liked throughout the region due to excellent insurance coverage, reimbursement regulations, and general awareness of sinus health.
Key players in the market
Some of the key players profiled in the Functional Endoscopic Sinus Surgery Market include Medtronic plc, Stryker Corporation, Karl Storz SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew plc, MediNatura, Inc., Holo Surgical, Inc., Conmed Corporation, B. Braun Melsungen AG, Cerebrospinal Fluid Technologies, Inc, Sino Medical Sciences Technology Inc, KARL STORZ Endoscopy-America, Inc., XION GmbH, Merck KGaA, Aesculap, Inc., Rudolf Medical GmbH, and Cavalier Surgical, LLC.
In June 2024, Olympus introduced its new 4K UHD endoscope system, which provides superior imaging quality and enhanced visualization for complex sinus surgeries, aiming to improve surgical outcomes and patient safety.
In August 2023, Medtronic announced the launch of its new ENT navigation system, designed to enhance the accuracy and efficiency of sinus surgeries by providing real-time, high-definition imaging and guidance.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.